Geron Corporation (GERN)
USD 1.3
(-6.16%)
USD 1.3
(-6.16%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -193.94 Million USD | -39.98% |
| 2022 | -138.55 Million USD | -21.54% |
| 2021 | -113.99 Million USD | -48.22% |
| 2020 | -76.91 Million USD | -6.08% |
| 2019 | -72.5 Million USD | -133.34% |
| 2018 | -31.07 Million USD | -6.21% |
| 2017 | -29.25 Million USD | 4.54% |
| 2016 | -30.64 Million USD | -5382.29% |
| 2015 | -559 Thousand USD | 98.46% |
| 2014 | -36.31 Million USD | 6.79% |
| 2013 | -38.95 Million USD | 45.71% |
| 2012 | -71.75 Million USD | 25.34% |
| 2011 | -96.11 Million USD | 13.54% |
| 2010 | -111.16 Million USD | -58.28% |
| 2009 | -70.23 Million USD | -4.76% |
| 2008 | -67.04 Million USD | -6.69% |
| 2007 | -62.83 Million USD | -32.68% |
| 2006 | -47.36 Million USD | -25.59% |
| 2005 | -37.71 Million USD | 53.61% |
| 2004 | -81.28 Million USD | -169.33% |
| 2003 | -30.18 Million USD | 15.46% |
| 2002 | -35.7 Million USD | -1.94% |
| 2001 | -35.01 Million USD | -33.6% |
| 2000 | -26.21 Million USD | -26.02% |
| 1999 | -20.8 Million USD | -65.08% |
| 1998 | -12.6 Million USD | -15.6% |
| 1997 | -10.9 Million USD | 10.66% |
| 1996 | -12.2 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -56.13 Million USD | -3.4% |
| 2024 Q2 | -69.33 Million USD | -23.51% |
| 2023 Q3 | -47.61 Million USD | 8.35% |
| 2023 FY | -193.94 Million USD | -39.98% |
| 2023 Q2 | -51.95 Million USD | -29.58% |
| 2023 Q4 | -54.28 Million USD | -14.02% |
| 2023 Q1 | -40.09 Million USD | 4.43% |
| 2022 Q1 | -28.67 Million USD | 7.45% |
| 2022 FY | -138.55 Million USD | -21.54% |
| 2022 Q4 | -41.95 Million USD | -5.01% |
| 2022 Q3 | -39.94 Million USD | -42.79% |
| 2022 Q2 | -27.97 Million USD | 2.44% |
| 2021 Q2 | -28.88 Million USD | -1.53% |
| 2021 Q3 | -25.67 Million USD | 11.13% |
| 2021 Q4 | -30.98 Million USD | -20.67% |
| 2021 Q1 | -28.45 Million USD | -22.3% |
| 2021 FY | -113.99 Million USD | -48.22% |
| 2020 Q4 | -23.26 Million USD | -16.24% |
| 2020 Q2 | -16.76 Million USD | 0.64% |
| 2020 Q1 | -16.87 Million USD | 43.78% |
| 2020 FY | -76.91 Million USD | -6.08% |
| 2020 Q3 | -20.01 Million USD | -19.41% |
| 2019 Q4 | -30 Million USD | -87.88% |
| 2019 Q3 | -15.97 Million USD | -4.91% |
| 2019 FY | -72.5 Million USD | -133.34% |
| 2019 Q2 | -15.22 Million USD | -34.71% |
| 2019 Q1 | -11.3 Million USD | -17.85% |
| 2018 Q1 | -7.43 Million USD | 4.48% |
| 2018 Q3 | -6.8 Million USD | 6.03% |
| 2018 FY | -31.07 Million USD | -6.21% |
| 2018 Q4 | -9.58 Million USD | -40.91% |
| 2018 Q2 | -7.24 Million USD | 2.62% |
| 2017 Q1 | -7.49 Million USD | 14.66% |
| 2017 FY | -29.25 Million USD | 4.54% |
| 2017 Q4 | -7.78 Million USD | -7.48% |
| 2017 Q3 | -7.24 Million USD | -7.62% |
| 2017 Q2 | -6.73 Million USD | 10.18% |
| 2016 FY | -30.64 Million USD | -5382.29% |
| 2016 Q3 | -3.87 Million USD | 56.49% |
| 2016 Q1 | -9.07 Million USD | -5.01% |
| 2016 Q2 | -8.91 Million USD | 1.83% |
| 2016 Q4 | -8.78 Million USD | -126.49% |
| 2015 FY | -559 Thousand USD | 98.46% |
| 2015 Q2 | -9.47 Million USD | -0.24% |
| 2015 Q4 | -8.64 Million USD | -131.99% |
| 2015 Q3 | 27.02 Million USD | 385.05% |
| 2015 Q1 | -9.45 Million USD | -4.94% |
| 2014 Q3 | -9.9 Million USD | -14.36% |
| 2014 Q4 | -9.01 Million USD | 9.04% |
| 2014 FY | -36.31 Million USD | 6.79% |
| 2014 Q1 | -8.73 Million USD | 5.87% |
| 2014 Q2 | -8.66 Million USD | 0.78% |
| 2013 Q2 | -8.96 Million USD | 25.2% |
| 2013 Q3 | -8.73 Million USD | 2.59% |
| 2013 Q4 | -9.27 Million USD | -6.21% |
| 2013 FY | -38.95 Million USD | 45.71% |
| 2013 Q1 | -11.98 Million USD | 35.16% |
| 2012 Q2 | -18.47 Million USD | 2.32% |
| 2012 Q3 | -15.87 Million USD | 14.08% |
| 2012 Q4 | -18.48 Million USD | -16.42% |
| 2012 FY | -71.75 Million USD | 25.34% |
| 2012 Q1 | -18.91 Million USD | 37.79% |
| 2011 Q3 | -19.93 Million USD | 6.91% |
| 2011 Q1 | -24.35 Million USD | 59.14% |
| 2011 Q4 | -30.4 Million USD | -52.53% |
| 2011 Q2 | -21.41 Million USD | 12.07% |
| 2011 FY | -96.11 Million USD | 13.54% |
| 2010 Q3 | -18.2 Million USD | -7.86% |
| 2010 Q1 | -16.47 Million USD | 10.31% |
| 2010 Q4 | -59.61 Million USD | -227.48% |
| 2010 Q2 | -16.87 Million USD | -2.42% |
| 2010 FY | -111.16 Million USD | -58.28% |
| 2009 Q4 | -18.37 Million USD | -12.02% |
| 2009 Q2 | -18.75 Million USD | -12.28% |
| 2009 Q1 | -16.7 Million USD | 26.42% |
| 2009 Q3 | -16.4 Million USD | 12.57% |
| 2009 FY | -70.23 Million USD | -4.76% |
| 2008 Q3 | -17.93 Million USD | -16.02% |
| 2008 Q2 | -15.45 Million USD | 3.08% |
| 2008 FY | -67.04 Million USD | -6.69% |
| 2008 Q1 | -15.94 Million USD | -11.25% |
| 2008 Q4 | -22.7 Million USD | -26.59% |
| 2007 Q2 | -16.76 Million USD | -2.22% |
| 2007 Q4 | -14.33 Million USD | 6.51% |
| 2007 Q3 | -15.33 Million USD | 8.54% |
| 2007 FY | -62.83 Million USD | -32.68% |
| 2007 Q1 | -16.4 Million USD | -26.21% |
| 2006 FY | -47.36 Million USD | -25.59% |
| 2006 Q4 | -12.99 Million USD | -7.46% |
| 2006 Q3 | -12.09 Million USD | -6.01% |
| 2006 Q2 | -11.4 Million USD | -5.03% |
| 2006 Q1 | -10.86 Million USD | -3.16% |
| 2005 FY | -37.71 Million USD | 53.61% |
| 2005 Q4 | -10.52 Million USD | 18.51% |
| 2005 Q3 | -12.92 Million USD | -231.56% |
| 2005 Q2 | -3.89 Million USD | 62.4% |
| 2005 Q1 | -10.36 Million USD | -7.6% |
| 2004 FY | -81.28 Million USD | -169.33% |
| 2004 Q2 | -9.16 Million USD | 82.37% |
| 2004 Q4 | -9.63 Million USD | 8.06% |
| 2004 Q1 | -52.01 Million USD | -530.74% |
| 2004 Q3 | -10.47 Million USD | -14.26% |
| 2003 Q1 | -8.04 Million USD | -5.34% |
| 2003 FY | -30.18 Million USD | 15.46% |
| 2003 Q4 | -8.24 Million USD | -57.46% |
| 2003 Q3 | -5.23 Million USD | 39.48% |
| 2003 Q2 | -8.65 Million USD | -7.57% |
| 2002 Q2 | -9.48 Million USD | 14.78% |
| 2002 Q3 | -7.44 Million USD | 21.56% |
| 2002 Q4 | -7.63 Million USD | -2.61% |
| 2002 FY | -35.7 Million USD | -1.94% |
| 2002 Q1 | -11.13 Million USD | -34.4% |
| 2001 Q2 | -7.42 Million USD | 15.96% |
| 2001 Q3 | -10.48 Million USD | -41.27% |
| 2001 FY | -35.01 Million USD | -33.6% |
| 2001 Q1 | -8.83 Million USD | -103.41% |
| 2001 Q4 | -8.28 Million USD | 20.98% |
| 2000 Q1 | -7.07 Million USD | -33.49% |
| 2000 Q4 | -4.34 Million USD | 31.57% |
| 2000 Q3 | -6.34 Million USD | 3.34% |
| 2000 Q2 | -6.56 Million USD | 7.24% |
| 2000 FY | -26.21 Million USD | -26.02% |
| 1999 FY | -20.8 Million USD | -65.08% |
| 1999 Q2 | -4.6 Million USD | -21.05% |
| 1999 Q3 | -6.9 Million USD | -50.0% |
| 1999 Q4 | -5.3 Million USD | 23.19% |
| 1999 Q1 | -3.8 Million USD | 0.0% |
| 1998 FY | -12.6 Million USD | -15.6% |
| 1998 Q2 | -3.3 Million USD | -50.0% |
| 1998 Q3 | -3.3 Million USD | 0.0% |
| 1998 Q4 | -3.8 Million USD | -15.15% |
| 1998 Q1 | -2.2 Million USD | -29.41% |
| 1997 Q3 | -2.3 Million USD | 0.0% |
| 1997 FY | -10.9 Million USD | 10.66% |
| 1997 Q2 | -2.3 Million USD | 50.0% |
| 1997 Q1 | -4.6 Million USD | -21.05% |
| 1997 Q4 | -1.7 Million USD | 26.09% |
| 1996 Q1 | -2.6 Million USD | 0.0% |
| 1996 Q4 | -3.8 Million USD | -22.58% |
| 1996 Q2 | -2.7 Million USD | -3.85% |
| 1996 FY | -12.2 Million USD | 0.0% |
| 1996 Q3 | -3.1 Million USD | -14.81% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | 18.239% |
| Alkermes plc | 414.12 Million USD | 146.833% |
| Agenus Inc. | -159.54 Million USD | -21.558% |
| Aptorum Group Limited | -10.52 Million USD | -1742.991% |
| Ardelyx, Inc. | -63.27 Million USD | -206.505% |
| Dyadic International, Inc. | -8.22 Million USD | -2256.624% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -16170.47% |
| Lantern Pharma Inc. | -17.87 Million USD | -984.845% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -865.386% |
| Novavax, Inc. | -566.51 Million USD | 65.765% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -165.753% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -135.953% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -898.758% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -1736.069% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -265.062% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 49.029% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -697.906% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -412.144% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -50.358% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -131.122% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1005.787% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -340.682% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -680.647% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -39.497% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 31.268% |
| AlloVir, Inc. | -181.33 Million USD | -6.956% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | 5.394% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -562.875% |
| Bicycle Therapeutics plc | -189.94 Million USD | -2.105% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -12.901% |
| ChromaDex Corporation | -5.59 Million USD | -3363.904% |
| Chimerix, Inc. | -93.06 Million USD | -108.396% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -330.248% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -67.108% |
| CRISPR Therapeutics AG | -222.53 Million USD | 12.849% |
| Precision BioSciences, Inc. | -43.73 Million USD | -343.442% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -1.802% |
| Fortress Biotech, Inc. | -142.34 Million USD | -36.252% |
| Fortress Biotech, Inc. | -142.34 Million USD | -36.252% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -98.522% |
| ImmuCell Corporation | -5.74 Million USD | -3274.067% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -44.272% |
| Immix Biopharma, Inc. | -16.14 Million USD | -1101.553% |
| Incyte Corporation | 620.52 Million USD | 131.255% |
| Innoviva, Inc. | 176.7 Million USD | 209.753% |
| IO Biotech, Inc. | -91.44 Million USD | -112.093% |
| Jaguar Health, Inc. | -34.29 Million USD | -465.583% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -14.124% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 1724.05% |
| ContextLogic Inc. | -328 Million USD | 40.871% |
| MiMedx Group, Inc. | 37.11 Million USD | 622.535% |
| MEI Pharma, Inc. | 14.54 Million USD | 1433.682% |
| NextCure, Inc. | -67.63 Million USD | -186.742% |
| Onconetix, Inc. | -36.03 Million USD | -438.216% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -364.937% |
| Opthea Limited | -191.84 Million USD | -1.095% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -6947.832% |
| Vaxcyte, Inc. | -468.04 Million USD | 58.563% |
| PDS Biotechnology Corporation | -43.04 Million USD | -350.559% |
| Precigen, Inc. | -88.92 Million USD | -118.103% |
| Pharming Group N.V. | -4.87 Million USD | -3874.634% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -15.918% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -551.781% |
| PureTech Health plc | -146.19 Million USD | -32.658% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -846.484% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 17.68% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -697.906% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 29.219% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -561.812% |
| Acelyrin, Inc. | -422.06 Million USD | 54.049% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -1503931.814% |
| Summit Therapeutics Inc. | -89.73 Million USD | -116.127% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -423.268% |
| Senti Biosciences, Inc. | -92.72 Million USD | -109.156% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -68.981% |
| Elevation Oncology, Inc. | -45.44 Million USD | -326.766% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -465.979% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -4819.879% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -6033.586% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -487.335% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2181.426% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -185.229% |
| Seer, Inc. | -103.46 Million USD | -87.453% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -194.931% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -169.618% |
| ESSA Pharma Inc. | -32.13 Million USD | -503.546% |
| GlycoMimetics, Inc. | -39.27 Million USD | -393.807% |
| GT Biopharma, Inc. | -13.57 Million USD | -1328.58% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 11.53% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -319.284% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 323.407% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -241.697% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -276.546% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -1851.609% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 61.543% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -2711.598% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -282.585% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 25.308% |
| Aptose Biosciences Inc. | -52.35 Million USD | -270.433% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1244.893% |
| Soligenix, Inc. | -7.69 Million USD | -2419.427% |
| Century Therapeutics, Inc. | -146.54 Million USD | -32.343% |
| Kura Oncology, Inc. | -165.8 Million USD | -16.972% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -107.52% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -2231.338% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -7715.158% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -2891.117% |
| Autolus Therapeutics plc | -195.02 Million USD | 0.556% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -129.094% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -163.289% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -817.644% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 14.575% |
| GRI Bio, Inc. | -11.38 Million USD | -1603.205% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -4194.868% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -47.831% |
| IGM Biosciences, Inc. | -263.46 Million USD | 26.386% |
| INmune Bio, Inc. | -29.74 Million USD | -552.11% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -75.332% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -409.369% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1113.716% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -1129.764% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -217.431% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -80.376% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 29.732% |
| Coherus BioSciences, Inc. | -203.19 Million USD | 4.555% |
| Verastem, Inc. | -92.08 Million USD | -110.616% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -311.465% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -5.321% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -63.832% |
| Histogen Inc. | -10.64 Million USD | -1722.268% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -1153.519% |
| Surrozen, Inc. | -45.78 Million USD | -323.644% |
| Organovo Holdings, Inc. | -15.08 Million USD | -1185.589% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3710.118% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -227.158% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -278.103% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -667.184% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -2440.914% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -13.23% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -300.314% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -147.994% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -1174.206% |
| Apollomics, Inc. | -54.83 Million USD | -253.693% |
| Amarin Corporation plc | -67.58 Million USD | -186.95% |
| Mesoblast Limited | -58.79 Million USD | -229.87% |
| Turnstone Biologics Corp. | -59.03 Million USD | -228.54% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -17.165% |
| Synaptogenix, Inc. | -8.31 Million USD | -2232.781% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -1229.659% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -111.519% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3947.696% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -2096.114% |
| Exelixis, Inc. | 170.88 Million USD | 213.494% |
| Better Therapeutics, Inc. | -38.26 Million USD | -406.884% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -25.074% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 62.495% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1542.61% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -2311.667% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -546.631% |
| Gritstone bio, Inc. | -154.63 Million USD | -25.421% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -181.646% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1032.649% |
| Avid Bioservices, Inc. | -18.67 Million USD | -938.355% |
| Insmed Incorporated | -709.62 Million USD | 72.67% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -1136.116% |
| MediWound Ltd. | -15.29 Million USD | -1168.437% |
| OmniAb, Inc. | -69.41 Million USD | -179.382% |
| Alector, Inc. | -151.74 Million USD | -27.813% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -79.606% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -271.911% |
| Zai Lab Limited | -366.57 Million USD | 47.093% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 38.776% |
| Aura Biosciences, Inc. | -84.99 Million USD | -128.194% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 21.0% |
| Immunic, Inc. | -99.22 Million USD | -95.463% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -35.475% |
| Veracyte, Inc. | -85.79 Million USD | -126.055% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 31.18% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1264.842% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -2715.701% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -932.022% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 133.521% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -661.969% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 599.83% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1039.97% |
| Galecto, Inc. | -39.9 Million USD | -386.014% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -360.959% |
| Fortrea Holdings Inc. | 63.1 Million USD | 407.36% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -38.092% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -571.598% |
| XBiotech Inc. | -37.51 Million USD | -417.046% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -181.646% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -188.951% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -79.734% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -655.469% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -263.927% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 65.927% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -147.088% |
| Vaxxinity, Inc. | -58.28 Million USD | -232.751% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -87.008% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -771.536% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -124.431% |
| NexImmune, Inc. | -29.19 Million USD | -564.363% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -3350.88% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -1230.08% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 104.792% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -661.79% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1555.536% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -52.637% |
| Ainos, Inc. | -13.2 Million USD | -1368.561% |
| Pluri Inc. | -22.15 Million USD | -775.278% |
| Prothena Corporation plc | -191.03 Million USD | -1.522% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -40.5% |
| Celularity Inc. | -192.28 Million USD | -0.862% |
| Rallybio Corporation | -78.93 Million USD | -145.71% |
| Cue Biopharma, Inc. | -52.14 Million USD | -271.904% |
| MeiraGTx Holdings plc | -137.06 Million USD | -41.502% |
| Omeros Corporation | -164.53 Million USD | -17.878% |
| Humacyte, Inc. | -100.04 Million USD | -93.853% |
| Immunocore Holdings plc | -59.64 Million USD | -225.142% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -945.013% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -692.158% |
| Blueprint Medicines Corporation | -486.27 Million USD | 60.117% |
| CalciMedica, Inc. | -21.87 Million USD | -786.601% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -159.77% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -47.503% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -13.222% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 40.672% |
| Pulmatrix, Inc. | -14.74 Million USD | -1215.767% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -442.577% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -118.243% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 62.362% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -187.108% |
| Cytokinetics, Incorporated | -496.2 Million USD | 60.915% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -463.479% |
| Nutriband Inc. | -4.87 Million USD | -3880.849% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -344.693% |
| Vor Biopharma Inc. | -126.03 Million USD | -53.88% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 104.572% |
| Evogene Ltd. | -26.39 Million USD | -634.887% |
| ProKidney Corp. | -151.52 Million USD | -27.997% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -200.525% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -2421.294% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 68.068% |
| CorMedix Inc. | -48.95 Million USD | -296.145% |
| BioLineRx Ltd. | -49.69 Million USD | -290.276% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -69.869% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -409.414% |
| Atai Life Sciences N.V. | -125.47 Million USD | -54.573% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -137.562% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -138.234% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 22.107% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -530.917% |
| MediciNova, Inc. | -9.9 Million USD | -1858.978% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -53.469% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2577.875% |
| GeoVax Labs, Inc. | -26.74 Million USD | -625.216% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 16.34% |
| Biomea Fusion, Inc. | -126.13 Million USD | -53.759% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 44.493% |
| Mereo BioPharma Group plc | -28.41 Million USD | -582.517% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -1.494% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 15.66% |
| Absci Corporation | -115.51 Million USD | -67.895% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -603.027% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -71.834% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 19.911% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -669.741% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 6.755% |
| Allakos Inc. | -196.05 Million USD | 1.077% |
| Imunon, Inc. | -21.03 Million USD | -822.207% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -75.255% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 280.78% |
| BioAtla, Inc. | -129.68 Million USD | -49.548% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1542.61% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -1124.162% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 40.823% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -364.448% |
| XOMA Corporation | -41.84 Million USD | -363.449% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -84.293% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -59.631% |
| aTyr Pharma, Inc. | -54.91 Million USD | -253.146% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -121.835% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -12.191% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 23.779% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -803.494% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -2261.497% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1054.016% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2193084.915% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 157.452% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -2868.218% |
| UroGen Pharma Ltd. | -65.53 Million USD | -195.935% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -117.236% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -2570.297% |
| Orgenesis Inc. | -53.63 Million USD | -261.593% |
| Entera Bio Ltd. | -8.89 Million USD | -2081.352% |
| GH Research PLC | -41.22 Million USD | -370.487% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -654.411% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -133.518% |
| Xencor, Inc. | -138.63 Million USD | -39.891% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -3662.555% |
| Replimune Group, Inc. | -234.77 Million USD | 17.391% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -802.438% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1290.08% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -2868.218% |
| Portage Biotech Inc. | -18.25 Million USD | -962.532% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2577.875% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -84.777% |
| OncoCyte Corporation | -25.13 Million USD | -671.579% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1615.581% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1592.79% |
| Purple Biotech Ltd. | 22.27 Million USD | 970.837% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -2481.789% |
| scPharmaceuticals Inc. | -55.39 Million USD | -250.105% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -926.284% |
| HilleVax, Inc. | -133.34 Million USD | -45.445% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -1509.627% |
| Tharimmune, Inc. | -9.45 Million USD | -1951.184% |
| Genprex, Inc. | -31.07 Million USD | -524.104% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -3.055% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -518.109% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -25252.157% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -3460.618% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1231311.586% |
| Savara Inc. | -60 Million USD | -223.202% |
| Curis, Inc. | -48.33 Million USD | -301.275% |
| Daré Bioscience, Inc. | -30.83 Million USD | -528.874% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -3617.339% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -2565.164% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -611.721% |
| BeiGene, Ltd. | -1.2 Billion USD | 83.942% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -872.672% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 60.191% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -107.09% |
| Erasca, Inc. | -141.52 Million USD | -37.039% |
| bluebird bio, Inc. | -244.26 Million USD | 20.6% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -4184.186% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 199.744% |
| DBV Technologies S.A. | -76.43 Million USD | -153.747% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -4184.186% |
| Moderna, Inc. | -4.23 Billion USD | 95.425% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -355.171% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -2949.434% |
| Molecular Templates, Inc. | -10.46 Million USD | -1753.086% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -188.448% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 48.521% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -35.331% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -273.019% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -25.496% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 6.816% |
| MacroGenics, Inc. | -168.24 Million USD | -15.275% |
| RenovoRx, Inc. | -11.39 Million USD | -1601.86% |
| Adicet Bio, Inc. | -152.03 Million USD | -27.563% |
| Prime Medicine, Inc. | -191.29 Million USD | -1.386% |
| Aditxt, Inc. | -26.06 Million USD | -644.152% |
| Adagene Inc. | -23.71 Million USD | -717.644% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2553.097% |
| Quantum-Si incorporated | -111.17 Million USD | -74.456% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -512.816% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1230.409% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 258.952% |
| SciSparc Ltd. | -5.77 Million USD | -3259.501% |
| Vericel Corporation | -6.46 Million USD | -2900.371% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2140.401% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -738.874% |
| Generation Bio Co. | -138.56 Million USD | -39.968% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -133.583% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -124.316% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 19.559% |
| Invivyd, Inc. | -207.78 Million USD | 6.66% |
| Relay Therapeutics, Inc. | -373 Million USD | 48.004% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -1967.963% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1002.863% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1785.331% |
| 2seventy bio, Inc. | -216.7 Million USD | 10.502% |
| ADMA Biologics, Inc. | 21.63 Million USD | 996.561% |
| Clene Inc. | -40.54 Million USD | -378.402% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -705.487% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -253.938% |
| GeoVax Labs, Inc. | -26.74 Million USD | -625.216% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 44.597% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -427.997% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1306.344% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -87.021% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -470.39% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -13.898% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 71.658% |
| Evaxion Biotech A/S | -22.19 Million USD | -773.74% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -135.42% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 13.078% |
| Trevena, Inc. | -35.28 Million USD | -449.603% |
| Surrozen, Inc. | -45.78 Million USD | -323.644% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -142.597% |
| Cingulate Inc. | -22.75 Million USD | -752.157% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 2688.681% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -334.2% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -2255.421% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -89.107% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -164.305% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -212.44% |
| Clearmind Medicine Inc. | -8.74 Million USD | -2118.696% |
| Kronos Bio, Inc. | -121.83 Million USD | -59.192% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -154.533% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -6512.513% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -92.353% |
| Statera Biopharma, Inc. | -98.34 Million USD | -97.21% |
| ImmunityBio, Inc. | -362.25 Million USD | 46.461% |
| Korro Bio, Inc. | -84.53 Million USD | -129.427% |
| Kineta, Inc. | -15.72 Million USD | -1133.505% |
| BioVie Inc. | -32.17 Million USD | -502.693% |
| Codexis, Inc. | -68.06 Million USD | -184.923% |
| Celularity Inc. | -192.28 Million USD | -0.862% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 12.876% |
| Celcuity Inc. | -66.23 Million USD | -192.833% |
| Virax Biolabs Group Limited | -6.49 Million USD | -2885.374% |
| Cibus, Inc. | -318.88 Million USD | 39.18% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -351.033% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -473.053% |
| IN8bio, Inc. | -30.33 Million USD | -539.299% |
| Kodiak Sciences Inc. | -277.32 Million USD | 30.065% |
| Annexon, Inc. | -143.72 Million USD | -34.943% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -56.671% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -200.009% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -727.265% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 45.172% |
| Eyenovia, Inc. | -25.4 Million USD | -663.365% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 694.191% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -3386.947% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -145.086% |
| Arcellx, Inc. | -89.88 Million USD | -115.781% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -327.077% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -41.351% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -523.434% |
| Moolec Science SA | -6.65 Million USD | -2814.783% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -217.223% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -348.394% |
| Royalty Pharma plc | 1.49 Billion USD | 112.998% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -18.142% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1979.189% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -785.805% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -13.446% |
| Humacyte, Inc. | -100.04 Million USD | -93.853% |
| Structure Therapeutics Inc. | -102.77 Million USD | -88.707% |
| 89bio, Inc. | -151.2 Million USD | -28.266% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -142.031% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -1233.865% |
| Genelux Corporation | -24.16 Million USD | -702.582% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -471.718% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -12.922% |
| Notable Labs, Ltd. | -14.65 Million USD | -1223.218% |
| Liquidia Corporation | -73.38 Million USD | -164.286% |
| Mustang Bio, Inc. | -50.72 Million USD | -282.336% |
| Immunovant, Inc. | -282.7 Million USD | 31.398% |
| Quantum-Si incorporated | -111.17 Million USD | -74.456% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -148.318% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -811.948% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -90.119% |
| Acasti Pharma Inc. | -11.31 Million USD | -1614.498% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -746.137% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1113.716% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 9.395% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -5185.914% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1120.849% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -565.171% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -368.645% |
| PepGen Inc. | -84.76 Million USD | -128.799% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -554.531% |
| United Therapeutics Corporation | 1.18 Billion USD | 116.368% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -747.028% |
| Solid Biosciences Inc. | -104.31 Million USD | -85.921% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -491.146% |
| Immuneering Corporation | -58.41 Million USD | -232.023% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3710.118% |
| Silo Pharma, Inc. | -3.85 Million USD | -4930.2% |
| Belite Bio, Inc | -31.66 Million USD | -512.429% |
| XOMA Corporation | -41.84 Million USD | -363.449% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -187.239% |
| Bionomics Limited | -17.89 Billion USD | 98.916% |
| Apogee Therapeutics, Inc. | -93 Million USD | -108.535% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 643.565% |
| uniQure N.V. | -282.87 Million USD | 31.437% |
| Cassava Sciences, Inc. | -105.95 Million USD | -83.04% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2553.097% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -49.759% |
| Forte Biosciences, Inc. | -32.48 Million USD | -497.008% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -2234.213% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -559.786% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -3386.947% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1264.842% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -2081.843% |
| Altimmune, Inc. | -95.92 Million USD | -102.175% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -163.891% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 643.565% |
| Compugen Ltd. | -12.99 Million USD | -1392.796% |
| Peak Bio, Inc. | -1356.23 USD | -14300129.312% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -290.985% |
| Benitec Biopharma Inc. | -22.49 Million USD | -762.357% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 19.958% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -552.0% |
| Zura Bio Limited | -62.63 Million USD | -209.627% |
| PolyPid Ltd. | -22.86 Million USD | -748.139% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -1091.595% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -552.0% |
| Instil Bio, Inc. | -159.16 Million USD | -21.848% |
| argenx SE | -425.04 Million USD | 54.371% |
| Immunome, Inc. | -109.53 Million USD | -77.069% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -285.092% |
| Verona Pharma plc | -67.83 Million USD | -185.923% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -644.221% |
| Shattuck Labs, Inc. | -91.95 Million USD | -110.907% |
| CervoMed Inc. | -7.81 Million USD | -2382.358% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -165.277% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -1355.927% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -302.591% |
| Moolec Science SA | -6.65 Million USD | -2814.783% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1079.103% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -43.421% |
| AnaptysBio, Inc. | -164.41 Million USD | -17.963% |
| Design Therapeutics, Inc. | -78.19 Million USD | -148.042% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -122.819% |
| NeurAxis, Inc. | -6.66 Million USD | -2810.108% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -378.886% |
| Lumos Pharma, Inc. | -36.61 Million USD | -429.699% |
| Achilles Therapeutics plc | -75.25 Million USD | -157.716% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -644.221% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1339.021% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 3861.294% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -6512.513% |
| Nutriband Inc. | -4.87 Million USD | -3880.849% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -75.071% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -249.77% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -281.509% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -193.414% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -258.339% |
| Palisade Bio, Inc. | -13.07 Million USD | -1383.887% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -327.105% |
| Beam Therapeutics Inc. | -176.48 Million USD | -9.893% |
| Neurogene Inc. | -55.58 Million USD | -248.927% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -77.679% |
| AEON Biopharma, Inc. | -48.42 Million USD | -300.471% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -100.542% |
| Sesen Bio, Inc. | -25.9 Million USD | -648.558% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -132.188% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -1440.841% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 57.889% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -167.734% |
| Athira Pharma, Inc. | -125.46 Million USD | -54.579% |
| Vaccinex, Inc. | -22.88 Million USD | -747.472% |
| HCW Biologics Inc. | -25.71 Million USD | -654.142% |
| XOMA Corporation | -41.84 Million USD | -363.449% |
| Nektar Therapeutics | -137.42 Million USD | -41.127% |
| Arvinas, Inc. | -401.5 Million USD | 51.695% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2193084.915% |
| Merus N.V. | -156.54 Million USD | -23.889% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -93.439% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -460.208% |
| Rezolute, Inc. | -70.42 Million USD | -175.399% |
| Clene Inc. | -40.54 Million USD | -378.402% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1084.14% |
| BeyondSpring Inc. | -23.11 Million USD | -739.076% |
| Synlogic, Inc. | -55.16 Million USD | -251.596% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -981.734% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1691.796% |
| Peak Bio, Inc. | -1356.23 USD | -14300129.312% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -378.839% |
| Krystal Biotech, Inc. | -109.72 Million USD | -76.751% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -49.717% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 43.459% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -3986.513% |
| MannKind Corporation | 8.67 Million USD | 2334.893% |
| Ikena Oncology, Inc. | -75.41 Million USD | -157.162% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -1910.407% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -188.478% |
| Gossamer Bio, Inc. | -183.75 Million USD | -5.543% |
| CohBar, Inc. | -12.38 Million USD | -1465.542% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -282.352% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -603.027% |
| Legend Biotech Corporation | -439.48 Million USD | 55.87% |
| Mural Oncology plc | -194.63 Million USD | 0.357% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -188.852% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1101.243% |
| Disc Medicine, Inc. | -91.12 Million USD | -112.833% |
| Champions Oncology, Inc. | -7.35 Million USD | -2536.542% |
| REGENXBIO Inc. | -268.12 Million USD | 27.667% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1709.485% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -247.844% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -397.795% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -69.595% |
| Vaxart, Inc. | -83.34 Million USD | -132.695% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -2176.336% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -353.203% |
| Cellectis S.A. | -106.62 Million USD | -81.892% |
| Longeveron Inc. | -21.02 Million USD | -822.269% |
| Repare Therapeutics Inc. | -116.22 Million USD | -66.871% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 27.585% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -156.387% |
| Revolution Medicines, Inc. | -487.18 Million USD | 60.191% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -2815.574% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -341.243% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -160.013% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -178.515% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -1661.366% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 104.502% |
| Denali Therapeutics Inc. | -196.69 Million USD | 1.401% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2140.401% |
| Veru Inc. | -93.78 Million USD | -106.803% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -731.343% |
| Cingulate Inc. | -22.75 Million USD | -752.157% |
| Passage Bio, Inc. | -108.38 Million USD | -78.933% |
| Context Therapeutics Inc. | -25.07 Million USD | -673.529% |
| Exicure, Inc. | -14.99 Million USD | -1193.305% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 5.882% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -377.718% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -1895.938% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -5.2% |
| Nuvalent, Inc. | -149.49 Million USD | -29.735% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -2260.419% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -118.575% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -833.59% |
| OmniAb, Inc. | -69.41 Million USD | -179.382% |
| Anew Medical, Inc. | -1.3 Million USD | -14809.136% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -1418.628% |
| Lipocine Inc. | -17.93 Million USD | -981.615% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -183.076% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -154.68% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -409.369% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -390.662% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -766.44% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 66.553% |
| Ocugen, Inc. | -65.53 Million USD | -195.958% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -106.618% |
| Q32 Bio Inc. | -92.1 Million USD | -110.575% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -804.632% |
| Alumis Inc. Common Stock | -158.17 Million USD | -22.614% |
| Equillium, Inc. | -14.52 Million USD | -1235.519% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -210.778% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -2353.947% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -928.057% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -313.077% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -78.806% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -1520.249% |
| Dominari Holdings Inc. | -21.79 Million USD | -789.815% |
| Edesa Biotech, Inc. | -9.22 Million USD | -2002.885% |
| vTv Therapeutics Inc. | -25.5 Million USD | -660.505% |
| Bio-Techne Corporation | 206.68 Million USD | 193.835% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 50.46% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 200.997% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -46.62% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -405.181% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -28.354% |
| Nkarta, Inc. | -131.65 Million USD | -47.318% |
| BioCardia, Inc. | -11.64 Million USD | -1565.613% |
| Iterum Therapeutics plc | -47.46 Million USD | -308.578% |